Fig. 1.
Published cases of patients receiving anti-TNF therapy in the context of chronic HBV infection.
Anti-TNF-α therapy for rheumatoid arthritis among patients with chronic hepatitis B infection
(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
This Article
-
Rheumatology (Oxford) April 1, 2009 vol. 48 no. 4 448-450
People also read [Beta]
The Journal
- About this journal
- Rights & Permissions
- Dispatch date of the next issue
- View eLetters
- We are mobile – find out more
Published on behalf of
Impact factor: 4.058
Alerting Services
Corporate Services
Most
-
Most Read
- Therapeutic ultrasound in soft tissue lesions
- A brief history of acupuncture
- Diet therapy for the patient with rheumatoid arthritis?
- The Common-Sense Model of self-regulation of health and illness: how can we use it to understand and respond to our patients' needs?
- Living with the hypermobility syndrome
-
Most Cited
- STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS
- A simplified disease activity index for rheumatoid arthritis for use in clinical practice
- Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
- REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE
- Update on the British Society for Rheumatology guidelines for prescribing TNF{alpha} blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)